Analysts expect GT Biopharma, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Low Estimate | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Consensus Estimate | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Analysts expect GT Biopharma, Inc. to report earnings per share of -2.34 for Q3 26, against a range of -2.57 to -2.11. The most recent reported quarter, Q2 26, came in at -3.00, a 58.7% miss against the -1.89 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -38.25 | -41.75 | -8.25 | -13.75 | -20.75 | -55.50 | -2.75 | -3.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -64.89 | -37.25 | -7.54 | -16.26 | -9.30 | -5.44 | -2.46 | -1.75 | -2.11 | -2.20 | 7.85 | -2.01 | -4.07 | -8.97 | 11.45 | -0.28 | ||||||||||
| Low Estimate | -77.79 | -43.43 | -8.56 | -19.12 | -10.28 | -6.20 | -2.88 | -2.03 | -2.57 | -2.66 | 6.89 | -2.27 | -4.91 | -10.13 | 10.11 | -0.30 | ||||||||||
| Consensus Estimate | -71.34 | -40.34 | -8.05 | -17.69 | -9.79 | -5.82 | -2.67 | -1.89 | -2.34 | -2.43 | 7.37 | -2.14 | -4.49 | -9.55 | 10.78 | -0.29 |
Pull Wall Street consensus for GT Biopharma, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=GTBP&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "GTBP", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=GTBP&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();